What is Kite Pharma Effective Interest Rate on Debt %?
Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Kite Pharma's annualized positive value of Interest Expense for the quarter that ended in Jun. 2017 was $0.00 Mil. Kite Pharma's average total debt for the quarter that ended in Jun. 2017 was $0.00 Mil. Therefore, Kite Pharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2017 was N/A%.
Kite Pharma Effective Interest Rate on Debt % Historical Data
The historical data trend for Kite Pharma's Effective Interest Rate on Debt % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Kite Pharma Effective Interest Rate on Debt % Chart
Competitive Comparison of Kite Pharma's Effective Interest Rate on Debt %
For the Biotechnology subindustry, Kite Pharma's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kite Pharma's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kite Pharma's Effective Interest Rate on Debt % distribution charts can be found below:
* The bar in red indicates where Kite Pharma's Effective Interest Rate on Debt % falls into.
Kite Pharma Effective Interest Rate on Debt % Calculation
Kite Pharma's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data,
the Interest Expense data used here is four times the quarterly (Jun. 2017) interest expense data.
Effective Interest Rate on Debt % is displayed in the 30-year financial page.
Kite Pharma (NAS:KITE) Effective Interest Rate on Debt % Explanation
Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.
Kite Pharma Effective Interest Rate on Debt % Related Terms
Thank you for viewing the detailed overview of Kite Pharma's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.
Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. In partnership with the National Cancer Institute through a cooperative research and development agreement, Kite is advancing a pipeline of proprietary product candidates, both chimeric antigen receptor and T-cell receptor products, targeting a wide range of cancer indications. The company also has a strategic collaboration with Amgen to develop and commercialize next-generation CAR-T therapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KITE has been successfully added to your 